U.S. Interactive Media and Services Stock News

LXP Industrial Trust (LXP) has put fresh numbers in front of investors with its Q4 2025 investor presentation, spotlighting 97.1% portfolio occupancy and a new approximately 1 million square foot Phoenix development tied to strong industrial demand. See our latest analysis for LXP Industrial Trust. At a share price of $49.09, LXP Industrial Trust has seen a 15.53% 1 year total shareholder return, even though its year to date share price return is slightly negative and short term moves remain...

Sea Limited recently confirmed it would release its fourth quarter 2025 results and host its earnings call on March 3, 2026, at 9:30 a.m. US Eastern Standard Time. This upcoming update follows a period where investors have become more focused on a projected slowdown in Sea’s revenue growth momentum. We’ll now examine how expectations for slower year-on-year revenue growth heading into this earnings release may influence Sea’s investment narrative. Uncover the next big thing with 30 elite...

If you are wondering whether Alignment Healthcare is attractively priced at its current level, this article will walk through how the market might be valuing the stock today and what that could mean for you. The share price closed at US$19.65 recently, with returns of a 1.3% decline over the last week, a 12.8% decline over the last month, a 2.8% decline year to date, and a 26.6% gain over the past year, as well as a very large gain over three years. These moves have come alongside ongoing...

Nexa Resources S.A. reported a turnaround in its 2025 results, with sales of US$3,002.06 million, net income of US$132.63 million, a US$12.5 million impairment on long-lived assets, and a proposed dividend of about US$17.5 million (US$0.132136 per share) for payment in August 2026, subject to AGM approval. The company’s return to profitability alongside a proposed cash dividend, while reaffirming 2026 production guidance after only minimal disruption at the Atacocha mine, highlights...

Limbach Holdings (LMB) is back in focus after reporting fourth quarter and full year 2025 results, with higher sales, net income and earnings per share compared with the prior year periods. See our latest analysis for Limbach Holdings. The latest earnings release comes after a strong run in the shares, with a 90 day share price return of 29.7% and a 1 year total shareholder return of 15.65%. The 3 year total shareholder return is around 7x, and recent weekly moves have cooled short term...

For investors wondering if Century Communities at around US$65.99 offers solid value, this article walks through what the numbers indicate about the stock today. The share price has seen mixed recent returns, with about a 5.7% decline over the last 7 days, a 4.8% gain over 30 days, around 12.0% year to date, and roughly a 1.0% decline over the past year. This combination can leave investors unsure how to interpret the risk and reward trade off. Recent coverage of homebuilders and housing...

Cytokinetics (NasdaqGS:CYTK) has secured regulatory approval from both the FDA and the European Commission for MYQORZO™, a treatment for obstructive hypertrophic cardiomyopathy (oHCM). MYQORZO™ is expected to reach patients in the U.S. and Europe with sales commencing in Q1 2026. The approvals open access to two major markets and introduce a new potential revenue source for Cytokinetics. Cytokinetics enters this phase with MYQORZO™ approved on both sides of the Atlantic and a current share...

If you are wondering whether American Financial Group at around US$134.50 is offering fair value or hiding a margin of safety, you are not alone. The stock closed at US$134.50 with returns of 3.8% over the past week, 3.2% over the past month, a slight year to date decline of 0.2%, and an 11.9% return over the past year, with 21.6% over three years and 96.8% over five years. Recent attention on American Financial Group has focused on its position as a specialist insurer and how investors are...

Recent performance snapshot THOR Industries (THO) has drawn investor attention after a stretch of weaker returns, with the stock down about 11% over the past week and about 14% over the past month. That share performance sits against annual revenue of roughly US$9.83b and net income of about US$282 million. This gives investors a current reference point as they think about the recreational vehicle maker’s valuation and prospects. See our latest analysis for THOR Industries. At around US$95.69...

Kimbell Royalty Partners, LP reported past fourth-quarter 2025 results showing revenue of US$82.45 million and net income of US$21.83 million, alongside full-year 2025 revenue of US$333.83 million and net income of US$90.95 million, and declared a Q4 2025 cash distribution of US$0.37 per common unit. The partnership also issued 2026 production guidance of 24.0–27.0 Mboe/d with a balanced mix of oil, natural gas, and NGLs, while highlighting a US$230 million Midland Basin acquisition and the...

In February 2026, Reliance, Inc. reported higher fourth-quarter and full-year 2025 sales and earnings than a year earlier, raised its quarterly dividend to US$1.25 per share, updated first-quarter 2026 volume guidance, and disclosed further progress on a long-running share repurchase program totaling about US$4.70 billion to date. The mix of earnings growth, a dividend increase, and continued buybacks highlights Reliance’s focus on returning cash to shareholders while managing volume and...

Doximity, Inc. recently presented at the ViVE 2026 conference in Los Angeles, where co-founder and CEO Jeffrey A. Tangney outlined the company’s latest digital healthcare tools and platform capabilities for medical professionals. This appearance, alongside upbeat analyst commentary on Doximity’s role in telemedicine and clinician workflow, has sharpened investor focus on its position in digital healthcare. Next, we’ll explore how this heightened attention on Doximity’s telemedicine and...

If you are wondering whether TJX Companies is still good value at around US$159.94 per share, it helps to step back and look at what the recent share price and fundamentals are really telling you. The stock has returned 1.4% over the last 7 days, 6.8% over the past month, 3.7% year to date, 31.0% over 1 year and 112.9% and 164.0% over 3 and 5 years respectively, so many investors are asking whether the current price already reflects these outcomes. Recent coverage around TJX has focused on...

Home Depot stock performance and recent context Home Depot (HD) has been relatively steady recently, with the share price near $370.81 and mixed returns across different time frames, including a small decline over the past month and a gain over the past 3 months. For investors watching large U.S. retailers, the company’s current valuation metrics sit alongside trailing annual revenue of about $164.7b and net income of roughly $14.2b. This provides a sense of its scale in home improvement. See...

Applied Industrial Technologies (AIT) is back in focus after director Peter C. Wallace sold 5,000 shares and the company released Q2 results highlighting solid sales, strong orders, and firm cash generation. See our latest analysis for Applied Industrial Technologies. AIT’s recent Q2 update and insider sale sit against a backdrop of steady price strength, with a 30 day share price return of 8.88% and a 1 year total shareholder return of 18.87%. This suggests momentum has been building rather...

If you are trying to figure out whether Healthpeak Properties is reasonably priced or offering a margin of safety, this article walks through what the current share price might be implying. The stock last closed at US$17.63, with returns of 1.9% over the past week, 2.3% over the past month, 8.8% year to date, and a 7.9% decline over the last year. This may leave you wondering whether the recent moves reflect changing risk or opportunity. Recent news flow around Healthpeak Properties has...

Tsakos Energy Navigation (NYSE:TEN) declared a regular quarterly cash dividend for its Series F Cumulative Redeemable Perpetual Preferred Shares. The dividend applies to the current quarter and is payable to holders of record as of the announced record date. This decision highlights the company’s ongoing approach to returning capital to preferred shareholders. Tsakos Energy Navigation operates in the international tanker shipping sector, focusing on the transport of crude oil and refined...

Why short interest around Mondelez International (MDLZ) matters now Recent attention on Mondelez International (MDLZ) has centered on short interest activity in the stock, coming at a time when the company reports consistent revenue growth and stable demand for its global snack brands. For you as an investor, that combination of evolving short positions and steady business performance raises practical questions about sentiment, potential risks, and whether current pricing reflects the...

Xeris Biopharma Holdings (XERS) closed out FY 2025 with fourth quarter revenue of US$85.8 million, basic EPS of US$0.07, and net income of US$11.1 million. On a trailing twelve month basis, revenue was US$291.8 million and basic EPS was US$0.00, reflecting a small net profit of US$0.6 million. The company has seen revenue move from US$203.1 million and basic EPS of a US$0.37 loss on a trailing basis in Q4 2024 to US$291.8 million and essentially breakeven EPS by Q4 2025. That shift toward...

Why Aptiv’s V2X Proof-of-Concept Matters for Investors Aptiv (APTV) is drawing fresh attention after unveiling a Vehicle to Everything proof of concept with Wind River. The project is built on Verizon’s 5G and edge compute platform at MWC Barcelona. The project focuses on sharing real time sensor data between vehicles to support safety features such as automatic emergency braking, positioning Aptiv squarely in the conversation around connected and automated driving systems. See our latest...

GRAIL (GRAL) has drawn fresh attention after releasing topline results from its large NHS-Galleri cancer screening trial alongside fourth quarter and full year 2025 earnings, combining key clinical readouts with updated revenue and loss figures. See our latest analysis for GRAIL. The earnings and NHS-Galleri updates arrive after a volatile stretch for investors, with a 7 day share price return of 22.31% contrasting with a 30 day share price return decline of 46.20% and a 1 year total...

If you are wondering whether MP Materials is fairly priced after its strong run, or if the current share price is getting ahead of itself, this article breaks down what the numbers are really saying about value. The stock last closed at US$63.73, with returns of 14.4% over 7 days, 8.4% over 30 days, 15.9% year to date and 182.9% over 1 year, while the 3 year and 5 year returns sit at 90.8% and 67.3% respectively. These moves have kept MP Materials on many investors' radar, especially as rare...

Vicor (VICR) is back on investors’ radar after its February 19 earnings release and the CEO’s outlook for record 2026 product and IP licensing revenues tied to high performance compute demand. See our latest analysis for Vicor. That upbeat guidance has coincided with very strong momentum in the stock, with a 30 day share price return of 32.68% and a 1 year total shareholder return of 245.08%, suggesting investors are reassessing both growth prospects and risk. If Vicor’s run has you thinking...

Vornado Realty Trust has recently been highlighted as a controversial New York–focused office REIT, with its fortunes closely tied to the uncertain post‑pandemic recovery in Manhattan’s office market and ongoing refinancing challenges. The coverage underscores that Vornado has effectively become a leveraged bet on New York office conditions, interest rates, and broader capital‑market sentiment, making macroeconomic shifts and Federal Reserve policy key drivers of risk for investors. Next,...